¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ /Jo*O=Lpo  
9]|cs  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© n}YRE`>D  
}PoB`H'K5  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 4Sw)IU~K(  
sqsBGFeG  
1.Co-stimulators (or co-stimulating molecules) lh .p`^v  
l.FkX  
2.NK-kB tL LP2^_&  
$2\ OBc=  
3.Immunoglobulin superfamily 2jaR_` `=:  
N U\B  
4.antigen-presenting cell (APC) O$KLQ'0"n  
'(~+ \  
5.death domain p'!cGJL  
)]?sCNb  
6.CCR and CXCR <Knl6$B  
M"1}"ex#  
7.Lectin (or mitogen) &h')snp:#  
O*X ]oX  
8.Clusters of differentiation, CD) Il,2^54q  
;3 O0O  
9.B7 family 7"FsW3an  
}e  s  
10.Cytotoxic T lymphocyte, CTL) t*iKkV^aE  
;3'ta!.c  
11.IL-15 and IL-15 receptor (IL-15R) F8S% \i  
=# <!s!  
12.MHC restriction Se {}OG)  
]MKW5Kq  
13.Affinity-chromatography tZB" (\  
TgoaEufS<  
14.Cyctosprin A, CsA 49W@?: b  
sIJl9  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) *eK\W00  
m&a.i B  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© H|JPqBNRh  
4YX/=  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 U[,."w]T  
Lyo!}T  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 6?i]oy^X]p  
42]hX9E  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ G9v'a&  
`1 A,sXfa  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Di) %vU  
wz`\R HL  
ÃâÒßѧרҵ£º ut j7"{'k|  
CiF(   
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£  B_Ul&V  
~F"<Nq  
Ïû»¯ÄÚ¿Æ£º *qa.h qas  
/ <C{$Gu  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ kz_gR;"(Z  
!\< [}2}  
ѪҺ²¡Ñ§×¨Òµ£º _sqj~|K  
"_^vQ1M]Z  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
freekaobo¹Ù·½Î¢ÐŶ©ÔĺŠÕýÈ·´ð°¸:¿¼²©
°´"Ctrl+Enter"Ö±½ÓÌá½»